I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
With a deep background in the manufacturing and innovation of medical technology, Faisal Zain has become a leading voice at the intersection of healthcare and venture capital. He focuses on how startups are leveraging technology to solve some of medicine’s most persistent challenges. Today, we d
The American healthcare system is in the midst of a profound transformation, moving decisively away from a fee-for-service model that rewards the sheer volume of procedures toward a value-based framework that prioritizes quality outcomes and cost-efficiency. For rehabilitation professionals,
A landmark public hospital funding agreement has been announced, injecting billions of dollars into a system teetering on the brink of collapse and raising a critical question across the healthcare industry: can this financial infusion alone mend a deeply fractured system, or is it merely an
A fundamental pillar of modern cancer prevention is on the verge of a significant transformation, as top public health officials re-examine whether the long-standing multi-dose Human Papillomavirus (HPV) vaccine schedule could be simplified to a single shot. This review, driven by compelling new
A groundbreaking federal policy framework unveiled this year seeks to fundamentally re-engineer the nation's sprawling healthcare industry, a multi-trillion-dollar behemoth teetering under the weight of its own inefficiency and escalating costs. The comprehensive proposal, poised to begin a
